You are here

Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Peking University First Hospital
Beijing, Beijing, 100034 China
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Postherpetic Neuralgia ( PHN )
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female Chinese subjects, ages ≥18 at screening

- Subjects with symptoms of neuropathic pain associated with postherpetic neuralgia
(PHN). Subjects must have pain present for ﹥3 months after healing of the acute herpes
zoster skin rash

- At screening (V1), subjects must have a score ≥40mm on the 100-mm visual analog scale
(VAS) of the Short Form-McGill Pain Questionnaire (SF-MPQ, see Appendix 3)

- At randomization (V2), subjects must have a score ≥40mm on the 100-mm visual analog
scale (VAS) of the Short Form-McGill Pain Questionnaire (SF-MPQ, see Appendix 3)

- At randomization (V2), subjects must have completed at least 5 daily pain diaries
(DPRS, see Appendix 2) and have an average daily pain score ≥4 over the past 7 days

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects who demonstrate a high response to placebo, with 30% decrease on the Pain
Visual Analog Scale (VAS) at randomization as compared to screening

- Subjects who have a high variability in pain scores during the 1 week screening
period, with any difference between two scores ?3

NCT01455428
Pfizer
Completed
Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now